INT84921

From wiki-pain
(Difference between revisions)
Jump to: navigation, search
(Generated page)
(Generated page)
Line 31: Line 31:
 
|-
 
|-
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"| Disease Relevance
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"| Disease Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;" align="center"| 6.39012
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;" align="center"| 6.39
 
|-
 
|-
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"| Pain Relevance
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"| Pain Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;" align="center"| 9.16416
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;" align="center"| 6.10
 
|-
 
|-
 
|}
 
|}
Line 113: Line 113:
 
|}
 
|}
 
{| cellspacing=2 cellpadding=2
 
{| cellspacing=2 cellpadding=2
|
+
| style="vertical-align: top"|
 
{| cellspacing=1 cellpadding=5 align=center
 
{| cellspacing=1 cellpadding=5 align=center
 
|-
 
|-
Line 123: Line 123:
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| [[Nerve growth factor]]
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| [[Nerve growth factor]]
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| 51
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| 51
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| 100
+
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| 100.00
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| {{#icon: chilli.png|Very High}} {{#icon: chilli.png|Very High}} {{#icon: chilli.png|Very High}}
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| {{#icon: chilli.png|Very High}} {{#icon: chilli.png|Very High}} {{#icon: chilli.png|Very High}}
 
|-
 
|-
Line 133: Line 133:
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| [[Inflammation]]
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| [[Inflammation]]
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| 53
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| 53
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| 98.8
+
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| 98.80
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| {{#icon: chilli.png|Very High}} {{#icon: chilli.png|Very High}} {{#icon: chilli.png|Very High}}
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| {{#icon: chilli.png|Very High}} {{#icon: chilli.png|Very High}} {{#icon: chilli.png|Very High}}
 
|-
 
|-
Line 174: Line 174:
 
|}
 
|}
 
|
 
|
|
+
| style="vertical-align: top"|
 
{| cellspacing=1 cellpadding=5 align=center
 
{| cellspacing=1 cellpadding=5 align=center
 
|-
 
|-
Line 184: Line 184:
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| [[INFLAMMATION]]
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| [[INFLAMMATION]]
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| 61
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| 61
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| 98.8
+
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| 98.80
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| {{#icon: chilli.png|Very High}} {{#icon: chilli.png|Very High}} {{#icon: chilli.png|Very High}}
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| {{#icon: chilli.png|Very High}} {{#icon: chilli.png|Very High}} {{#icon: chilli.png|Very High}}
 
|-
 
|-
Line 204: Line 204:
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| [[Cold Sores]]
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| [[Cold Sores]]
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| 4
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| 4
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| 98.4
+
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| 98.40
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| {{#icon: chilli.png|Very High}} {{#icon: chilli.png|Very High}} {{#icon: chilli.png|Very High}}
 
| style="background:#E0FFFF; border: 1px solid white; white-space:wrap;"| {{#icon: chilli.png|Very High}} {{#icon: chilli.png|Very High}} {{#icon: chilli.png|Very High}}
 
|-
 
|-
Line 251: Line 251:
 
|}
 
|}
 
{| style="color: black; background-color: white;" cellpadding=6 cellspacing=6 class="wikitable"
 
{| style="color: black; background-color: white;" cellpadding=6 cellspacing=6 class="wikitable"
| Congenital insensitivity to pain with anhidrosis (CIPA) is identified as a genetic disorder of mutations in the human <span style="background-color:#FFFF00">TrkA</span> known as high affinity <span style="background-color:#B0E0E6">receptor</span> of <span style="background-color:#FFFF00">nerve growth factor</span> (NGF).  
+
| <span style="background-color:#FFA07A">Congenital insensitivity to pain with anhidrosis</span> (<span style="background-color:#FFA07A">CIPA</span>) is identified as a genetic disorder of mutations in the human <span style="background-color:#FFFF00">TrkA</span> known as high affinity <span style="background-color:#B0E0E6">receptor</span> of <span style="background-color:#FFFF00">nerve growth factor</span> (<span style="background-color:#FFA07A">NGF</span>).  
 
|-
 
|-
 
|
 
|
 
{| cellpadding=4 cellspacing=2  
 
{| cellpadding=4 cellspacing=2  
 
|-
 
|-
| <span style="color:#800000">'''nerve growth factor'''</span> <span style="color:#000080">'''Binding'''</span> (<span style="color:#000080">receptor</span>) of <span style="color:#800000">'''TrkA'''</span> in <span style="color:#808000">nerve</span>
+
| <span style="color:#800000">'''nerve growth factor'''</span> <span style="color:#000080">'''Binding'''</span> (<span style="color:#000080">receptor</span>) of <span style="color:#800000">'''TrkA'''</span> in <span style="color:#808000">nerve</span> associated with <span style="color:#FF0000">'''nerve growth factor'''</span> and <span style="color:#FF0000">'''hsan'''</span>
 
|-
 
|-
 
|}
 
|}
Line 275: Line 275:
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=15114061 15114061]
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=15114061 15114061]
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 0.92
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 0.89
 
|}
 
|}
 
|-
 
|-
 
|}
 
|}
 
{| style="color: black; background-color: white;" cellpadding=6 cellspacing=6 class="wikitable"
 
{| style="color: black; background-color: white;" cellpadding=6 cellspacing=6 class="wikitable"
| Congenital insensitivity to pain with anhidrosis (CIPA) is identified as a genetic disorder of mutations in the human <span style="background-color:#FFFF00">TrkA</span> known as high affinity <span style="background-color:#B0E0E6">receptor</span> of <span style="background-color:#FFDEAD">nerve</span> growth factor (<span style="background-color:#FFFF00">NGF</span>).  
+
| <span style="background-color:#FFA07A">Congenital insensitivity to pain with anhidrosis</span> (<span style="background-color:#FFA07A">CIPA</span>) is identified as a genetic disorder of mutations in the human <span style="background-color:#FFFF00">TrkA</span> known as high affinity <span style="background-color:#B0E0E6">receptor</span> of <span style="background-color:#FFA07A">nerve growth factor</span> (<span style="background-color:#FFFF00">NGF</span>).  
 
|-
 
|-
 
|
 
|
 
{| cellpadding=4 cellspacing=2  
 
{| cellpadding=4 cellspacing=2  
 
|-
 
|-
| <span style="color:#800000">'''NGF'''</span> <span style="color:#000080">'''Binding'''</span> (<span style="color:#000080">receptor</span>) of <span style="color:#800000">'''TrkA'''</span> in <span style="color:#808000">nerve</span>
+
| <span style="color:#800000">'''NGF'''</span> <span style="color:#000080">'''Binding'''</span> (<span style="color:#000080">receptor</span>) of <span style="color:#800000">'''TrkA'''</span> in <span style="color:#808000">nerve</span> associated with <span style="color:#FF0000">'''nerve growth factor'''</span> and <span style="color:#FF0000">'''hsan'''</span>
 
|-
 
|-
 
|}
 
|}
Line 306: Line 306:
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=15114061 15114061]
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=15114061 15114061]
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 0.92
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 0.89
 
|}
 
|}
 
|-
 
|-
 
|}
 
|}
 
{| style="color: black; background-color: white;" cellpadding=6 cellspacing=6 class="wikitable"
 
{| style="color: black; background-color: white;" cellpadding=6 cellspacing=6 class="wikitable"
| <span style="background-color:#FFFF00">Nerve growth factor</span> (NGF) and its high-<span style="background-color:#B0E0E6">affinity</span> receptor <span style="background-color:#FFFF00">TrkA</span> are involved in stimulating epithelial cancer cell growth and perineural invasion, as well as in pain generation in chronic benign disorders.
+
| <span style="background-color:#FFFF00">Nerve growth factor</span> (NGF) and its high-<span style="background-color:#B0E0E6">affinity</span> receptor <span style="background-color:#FFFF00">TrkA</span> are involved in stimulating ep<span style="background-color:#FFA07A">itheli</span>al cancer cell growth and perineural invasion, as we<span style="background-color:#FFA07A">ll a</span>s in pain generation in chronic benign disorders.
  
 
|-
 
|-
Line 319: Line 319:
 
{| cellpadding=4 cellspacing=2  
 
{| cellpadding=4 cellspacing=2  
 
|-
 
|-
| <span style="color:#800000">'''Nerve growth factor'''</span> <span style="color:#000080">'''Binding'''</span> (<span style="color:#000080">affinity</span>) of <span style="color:#800000">'''TrkA'''</span> in <span style="color:#808000">Nerve</span>
+
| <span style="color:#800000">'''Nerve growth factor'''</span> <span style="color:#000080">'''Binding'''</span> (<span style="color:#000080">affinity</span>) of <span style="color:#800000">'''TrkA'''</span> in <span style="color:#808000">Nerve</span> associated with <span style="color:#FF0000">'''pain'''</span> and <span style="color:#FF0000">'''cancer'''</span>
 
|-
 
|-
 
|}
 
|}
Line 338: Line 338:
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=10561305 10561305]
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=10561305 10561305]
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 0.54
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 0.36
 
|}
 
|}
 
|-
 
|-
 
|}
 
|}
 
{| style="color: black; background-color: white;" cellpadding=6 cellspacing=6 class="wikitable"
 
{| style="color: black; background-color: white;" cellpadding=6 cellspacing=6 class="wikitable"
| <span style="background-color:#FFDEAD">Nerve</span> growth factor (<span style="background-color:#FFFF00">NGF</span>) and its high-<span style="background-color:#B0E0E6">affinity</span> receptor <span style="background-color:#FFFF00">TrkA</span> are involved in stimulating epithelial cancer cell growth and perineural invasion, as well as in pain generation in chronic benign disorders.
+
| <span style="background-color:#FFDEAD">Nerve</span> growth factor (<span style="background-color:#FFFF00">NGF</span>) and its high-<span style="background-color:#B0E0E6">affinity</span> receptor <span style="background-color:#FFFF00">TrkA</span> are involved in stimulating ep<span style="background-color:#FFA07A">itheli</span>al cancer cell growth and perineural invasion, as we<span style="background-color:#FFA07A">ll a</span>s in pain generation in chronic benign disorders.
  
 
|-
 
|-
Line 351: Line 351:
 
{| cellpadding=4 cellspacing=2  
 
{| cellpadding=4 cellspacing=2  
 
|-
 
|-
| <span style="color:#800000">'''NGF'''</span> <span style="color:#000080">'''Binding'''</span> (<span style="color:#000080">affinity</span>) of <span style="color:#800000">'''TrkA'''</span> in <span style="color:#808000">Nerve</span>
+
| <span style="color:#800000">'''NGF'''</span> <span style="color:#000080">'''Binding'''</span> (<span style="color:#000080">affinity</span>) of <span style="color:#800000">'''TrkA'''</span> in <span style="color:#808000">Nerve</span> associated with <span style="color:#FF0000">'''pain'''</span> and <span style="color:#FF0000">'''cancer'''</span>
 
|-
 
|-
 
|}
 
|}
Line 370: Line 370:
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=10561305 10561305]
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=10561305 10561305]
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 0.54
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 0.36
 
|}
 
|}
 
|-
 
|-
 
|}
 
|}
 
{| style="color: black; background-color: white;" cellpadding=6 cellspacing=6 class="wikitable"
 
{| style="color: black; background-color: white;" cellpadding=6 cellspacing=6 class="wikitable"
| <span style="background-color:#B0E0E6">Interactions</span> of <span style="background-color:#FFDEAD">nerve</span> growth factor (<span style="background-color:#FFFF00">NGF</span>) and its receptor tropomyosin-related kinase (<span style="background-color:#FFFF00">trkA</span>) appear to be critical for maintaining HSV latency.  
+
| <span style="background-color:#B0E0E6">Interactions</span> of <span style="background-color:#FFA07A">nerve growth factor</span> (<span style="background-color:#FFFF00">NGF</span>) and its receptor tropomyosin-related kinase (<span style="background-color:#FFFF00">trkA</span>) appear to be critical for maintaining <span style="background-color:#FFA07A">HSV</span> latency.  
 
|-
 
|-
 
|
 
|
 
{| cellpadding=4 cellspacing=2  
 
{| cellpadding=4 cellspacing=2  
 
|-
 
|-
| <span style="color:#800000">'''NGF'''</span> <span style="color:#000080">'''Binding'''</span> (<span style="color:#000080">Interactions</span>) of <span style="color:#800000">'''trkA'''</span> in <span style="color:#808000">nerve</span>
+
| <span style="color:#800000">'''NGF'''</span> <span style="color:#000080">'''Binding'''</span> (<span style="color:#000080">Interactions</span>) of <span style="color:#800000">'''trkA'''</span> in <span style="color:#808000">nerve</span> associated with <span style="color:#FF0000">'''cold sores'''</span> and <span style="color:#FF0000">'''nerve growth factor'''</span>
 
|-
 
|-
 
|}
 
|}
Line 401: Line 401:
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=19016376 19016376]
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=19016376 19016376]
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 0.40
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 0.23
 
|}
 
|}
 
|-
 
|-
Line 413: Line 413:
 
{| cellpadding=4 cellspacing=2  
 
{| cellpadding=4 cellspacing=2  
 
|-
 
|-
| <span style="color:#800000">'''nerve growth factor'''</span> <span style="color:#000080">'''Binding'''</span> (<span style="color:#000080">presence</span>) of <span style="color:#800000">'''TrkA'''</span> in <span style="color:#808000">nerve</span>
+
| <span style="color:#800000">'''nerve growth factor'''</span> <span style="color:#000080">'''Binding'''</span> (<span style="color:#000080">presence</span>) of <span style="color:#800000">'''TrkA'''</span> in <span style="color:#808000">nerve</span> associated with <span style="color:#FF0000">'''nerve growth factor'''</span>
 
|-
 
|-
 
|}
 
|}
Line 432: Line 432:
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=19399531 19399531]
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=19399531 19399531]
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 0.09
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 0.18
 
|}
 
|}
 
|-
 
|-
Line 463: Line 463:
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=19399531 19399531]
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=19399531 19399531]
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 0.34
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 0.26
 
|}
 
|}
 
|-
 
|-
Line 475: Line 475:
 
{| cellpadding=4 cellspacing=2  
 
{| cellpadding=4 cellspacing=2  
 
|-
 
|-
| <span style="color:#800000">'''nerve growth factor'''</span> <span style="color:#000080">'''Binding'''</span> (<span style="color:#000080">presence</span>) of <span style="color:#800000">'''TrkA'''</span> in <span style="color:#808000">nerve</span>
+
| <span style="color:#800000">'''nerve growth factor'''</span> <span style="color:#000080">'''Binding'''</span> (<span style="color:#000080">presence</span>) of <span style="color:#800000">'''TrkA'''</span> in <span style="color:#808000">nerve</span> associated with <span style="color:#FF0000">'''nerve growth factor'''</span>
 
|-
 
|-
 
|}
 
|}
Line 494: Line 494:
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=19399531 19399531]
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=19399531 19399531]
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 0.09
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 0.18
 
|}
 
|}
 
|-
 
|-
 
|}
 
|}
 
{| style="color: black; background-color: white;" cellpadding=6 cellspacing=6 class="wikitable"
 
{| style="color: black; background-color: white;" cellpadding=6 cellspacing=6 class="wikitable"
| The purpose of this study was to prove the <span style="background-color:#B0E0E6">presence</span> of <span style="background-color:#FFFF00">NGF</span> (<span style="background-color:#FFDEAD">nerve</span> growth factor) and its receptor <span style="background-color:#FFFF00">TrkA</span> (tyrosine kinase receptor) with immunofluorescence.  
+
| The purpose of this study was to prove the <span style="background-color:#B0E0E6">presence</span> of <span style="background-color:#FFFF00">NGF</span> (<span style="background-color:#FFA07A">nerve growth factor</span>) and its receptor <span style="background-color:#FFFF00">TrkA</span> (tyrosine kinase receptor) with immunofluorescence.  
 
|-
 
|-
 
|
 
|
 
{| cellpadding=4 cellspacing=2  
 
{| cellpadding=4 cellspacing=2  
 
|-
 
|-
| <span style="color:#800000">'''NGF'''</span> <span style="color:#000080">'''Binding'''</span> (<span style="color:#000080">presence</span>) of <span style="color:#800000">'''TrkA'''</span> in <span style="color:#808000">nerve</span>
+
| <span style="color:#800000">'''NGF'''</span> <span style="color:#000080">'''Binding'''</span> (<span style="color:#000080">presence</span>) of <span style="color:#800000">'''TrkA'''</span> in <span style="color:#808000">nerve</span> associated with <span style="color:#FF0000">'''nerve growth factor'''</span>
 
|-
 
|-
 
|}
 
|}
Line 525: Line 525:
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=19399531 19399531]
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=19399531 19399531]
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 0.09
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 0.18
 
|}
 
|}
 
|-
 
|-
 
|}
 
|}
 
{| style="color: black; background-color: white;" cellpadding=6 cellspacing=6 class="wikitable"
 
{| style="color: black; background-color: white;" cellpadding=6 cellspacing=6 class="wikitable"
| This study demonstrated the <span style="background-color:#B0E0E6">presence</span> of <span style="background-color:#FFFF00">NGF</span> and <span style="background-color:#FFFF00">TrkA</span> in specimens collected from degenerative facet <span style="background-color:#FFDEAD">joints</span>, suggesting that specific molecules could be used in order to modulate chronic pain in patients with degenerative lumbar spine.
+
| This study demonstrated the <span style="background-color:#B0E0E6">presence</span> of <span style="background-color:#FFFF00">NGF</span> and <span style="background-color:#FFFF00">TrkA</span> in specimens collected from degenerative <span style="background-color:#FFA07A">facet joints</span>, suggesting that specific molecules could be used in order to modulate <span style="background-color:#FFA07A">chronic pain</span> in patients with degenerative lumbar spine.
  
 
|-
 
|-
Line 538: Line 538:
 
{| cellpadding=4 cellspacing=2  
 
{| cellpadding=4 cellspacing=2  
 
|-
 
|-
| <span style="color:#800000">'''NGF'''</span> <span style="color:#000080">'''Binding'''</span> (<span style="color:#000080">presence</span>) of <span style="color:#800000">'''TrkA'''</span> in <span style="color:#808000">joints</span>
+
| <span style="color:#800000">'''NGF'''</span> <span style="color:#000080">'''Binding'''</span> (<span style="color:#000080">presence</span>) of <span style="color:#800000">'''TrkA'''</span> in <span style="color:#808000">joints</span> associated with <span style="color:#FF0000">'''facet joint'''</span> and <span style="color:#FF0000">'''lasting pain'''</span>
 
|-
 
|-
 
|}
 
|}
Line 557: Line 557:
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=19399531 19399531]
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=19399531 19399531]
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 0.67
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 0.52
 
|}
 
|}
 
|-
 
|-
 
|}
 
|}
 
{| style="color: black; background-color: white;" cellpadding=6 cellspacing=6 class="wikitable"
 
{| style="color: black; background-color: white;" cellpadding=6 cellspacing=6 class="wikitable"
| The purpose of this study was to prove the <span style="background-color:#B0E0E6">presence</span> of <span style="background-color:#FFFF00">NGF</span> (<span style="background-color:#FFDEAD">nerve</span> growth factor) and its receptor <span style="background-color:#FFFF00">TrkA</span> (tyrosine kinase receptor) with immunofluorescence.  
+
| The purpose of this study was to prove the <span style="background-color:#B0E0E6">presence</span> of <span style="background-color:#FFFF00">NGF</span> (<span style="background-color:#FFA07A">nerve growth factor</span>) and its receptor <span style="background-color:#FFFF00">TrkA</span> (tyrosine kinase receptor) with immunofluorescence.  
 
|-
 
|-
 
|
 
|
 
{| cellpadding=4 cellspacing=2  
 
{| cellpadding=4 cellspacing=2  
 
|-
 
|-
| <span style="color:#800000">'''NGF'''</span> <span style="color:#000080">'''Binding'''</span> (<span style="color:#000080">presence</span>) of <span style="color:#800000">'''TrkA'''</span> in <span style="color:#808000">nerve</span>
+
| <span style="color:#800000">'''NGF'''</span> <span style="color:#000080">'''Binding'''</span> (<span style="color:#000080">presence</span>) of <span style="color:#800000">'''TrkA'''</span> in <span style="color:#808000">nerve</span> associated with <span style="color:#FF0000">'''nerve growth factor'''</span>
 
|-
 
|-
 
|}
 
|}
Line 588: Line 588:
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=19399531 19399531]
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=19399531 19399531]
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 0.09
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 0.18
 
|}
 
|}
 
|-
 
|-
 
|}
 
|}
 
{| style="color: black; background-color: white;" cellpadding=6 cellspacing=6 class="wikitable"
 
{| style="color: black; background-color: white;" cellpadding=6 cellspacing=6 class="wikitable"
| There is considerable evidence showing that the system constituted by the <span style="background-color:#FFFF00">NGF</span> and its high-<span style="background-color:#B0E0E6">affinity</span> receptor <span style="background-color:#FFFF00">TrkA</span> plays a fundamental role in the molecular processes underlying the main forms of "persistent" pain.  
+
| There is considerable evidence showing that the system constituted by the <span style="background-color:#FFFF00">NGF</span> and its high-<span style="background-color:#B0E0E6">affinity</span> receptor <span style="background-color:#FFFF00">TrkA</span> plays a fundamental role in the molecular processes underlying the main forms of "persistent" <span style="background-color:#FFA07A">pain</span>.  
 
|-
 
|-
 
|
 
|
 
{| cellpadding=4 cellspacing=2  
 
{| cellpadding=4 cellspacing=2  
 
|-
 
|-
| <span style="color:#800000">'''NGF'''</span> <span style="color:#000080">'''Binding'''</span> (<span style="color:#000080">affinity</span>) of <span style="color:#800000">'''TrkA'''</span>
+
| <span style="color:#800000">'''NGF'''</span> <span style="color:#000080">'''Binding'''</span> (<span style="color:#000080">affinity</span>) of <span style="color:#800000">'''TrkA'''</span> associated with <span style="color:#FF0000">'''pain'''</span>
 
|-
 
|-
 
|}
 
|}
Line 619: Line 619:
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=19399531 19399531]
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=19399531 19399531]
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 0.61
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 0.48
 
|}
 
|}
 
|-
 
|-
 
|}
 
|}
 
{| style="color: black; background-color: white;" cellpadding=6 cellspacing=6 class="wikitable"
 
{| style="color: black; background-color: white;" cellpadding=6 cellspacing=6 class="wikitable"
| Only a few small molecule NGF antagonists are available, but ALE0540, which inhibits the <span style="background-color:#B0E0E6">binding</span> of <span style="background-color:#FFFF00">NGF</span> to <span style="background-color:#FFFF00">TrkA</span> and p75, and PD90780, which inhibits NGF binding to p75, have been proposed to have efficacy in chronic pain models [154,155].  
+
| Only a few small molecule <span style="background-color:#FFA07A">NGF</span> <span style="background-color:#FFA07A">antagonists</span> are available, but ALE0540, which inhibits the <span style="background-color:#B0E0E6">binding</span> of <span style="background-color:#FFFF00">NGF</span> to <span style="background-color:#FFFF00">TrkA</span> and p75, and PD90780, which inhibits <span style="background-color:#FFA07A">NGF</span> binding to p75, have been proposed to have efficacy in <span style="background-color:#FFA07A">chronic pain</span> models [154,155].  
 
|-
 
|-
 
|
 
|
 
{| cellpadding=4 cellspacing=2  
 
{| cellpadding=4 cellspacing=2  
 
|-
 
|-
| <span style="color:#800000">'''NGF'''</span> <span style="color:#000080">'''Binding'''</span> (<span style="color:#000080">binding</span>) of <span style="color:#800000">'''TrkA'''</span>
+
| <span style="color:#800000">'''NGF'''</span> <span style="color:#000080">'''Binding'''</span> (<span style="color:#000080">binding</span>) of <span style="color:#800000">'''TrkA'''</span> associated with <span style="color:#FF0000">'''nerve growth factor'''</span>, <span style="color:#FF0000">'''lasting pain'''</span> and <span style="color:#FF0000">'''antagonist'''</span>
 
|-
 
|-
 
|}
 
|}
Line 650: Line 650:
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=PMC2206352 PMC2206352]
 
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| [http://www.ncbi.nlm.nih.gov/pubmed?term=PMC2206352 PMC2206352]
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Disease Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 1.10
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
 
! style="color: black; background:#AAFCFB; border: 1px solid lightgray; white-space:nowrap;"|    Pain Relevance
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| N/A
+
| style="color: black; background:#F1FEFE; border: 1px solid lightgray; white-space:nowrap;"  align="center"| 1.39
 
|}
 
|}
 
|-
 
|-

Revision as of 13:32, 14 September 2012

Context Info
Confidence 0.50
First Reported 1999
Last Reported 2009
Negated 0
Speculated 0
Reported most in Abstract
Documents 13
Total Number 13
Disease Relevance 6.39
Pain Relevance 6.10

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

endosome (NGF, NTRK1) cell differentiation (NTRK1) signal transduction (NGF)
extracellular space (NGF) extracellular region (NGF) plasma membrane (NTRK1)
Anatomy Mention Frequency
nerve 9
joints 1
NGF (Homo sapiens)
NTRK1 (Homo sapiens)
Pain Term Frequency Confidence Heat
Nerve growth factor 51 100.00 Very High Very High Very High
antagonist 14 99.04 Very High Very High Very High
Inflammation 53 98.80 Very High Very High Very High
Hsan 16 98.72 Very High Very High Very High
Facet joint 28 98.32 Very High Very High Very High
Pain 110 97.92 Very High Very High Very High
Action potential 8 96.76 Very High Very High Very High
Lasting pain 29 96.12 Very High Very High Very High
Neuronal excitability 1 96.12 Very High Very High Very High
Hyperalgesia 10 89.84 High High
Disease Term Frequency Confidence Heat
INFLAMMATION 61 98.80 Very High Very High Very High
Pancreatic Cancer 4 98.76 Very High Very High Very High
Cancer 4 98.76 Very High Very High Very High
Hereditary Sensory And Autonomic Neuropathies 16 98.72 Very High Very High Very High
Cold Sores 4 98.40 Very High Very High Very High
Pain 145 97.92 Very High Very High Very High
Nociception 16 97.36 Very High Very High Very High
Apoptosis 9 96.72 Very High Very High Very High
Hyperalgesia 18 90.92 High High
Headache 1 86.36 High High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Congenital insensitivity to pain with anhidrosis (CIPA) is identified as a genetic disorder of mutations in the human TrkA known as high affinity receptor of nerve growth factor (NGF).
nerve growth factor Binding (receptor) of TrkA in nerve associated with nerve growth factor and hsan
1) Confidence 0.50 Published 2004 Journal J. Clin. Immunol. Section Abstract Doc Link 15114061 Disease Relevance 0.92 Pain Relevance 0.89
Congenital insensitivity to pain with anhidrosis (CIPA) is identified as a genetic disorder of mutations in the human TrkA known as high affinity receptor of nerve growth factor (NGF).
NGF Binding (receptor) of TrkA in nerve associated with nerve growth factor and hsan
2) Confidence 0.50 Published 2004 Journal J. Clin. Immunol. Section Abstract Doc Link 15114061 Disease Relevance 0.92 Pain Relevance 0.89
Nerve growth factor (NGF) and its high-affinity receptor TrkA are involved in stimulating epithelial cancer cell growth and perineural invasion, as well as in pain generation in chronic benign disorders.
Nerve growth factor Binding (affinity) of TrkA in Nerve associated with pain and cancer
3) Confidence 0.36 Published 1999 Journal J. Clin. Oncol. Section Abstract Doc Link 10561305 Disease Relevance 0.54 Pain Relevance 0.36
Nerve growth factor (NGF) and its high-affinity receptor TrkA are involved in stimulating epithelial cancer cell growth and perineural invasion, as well as in pain generation in chronic benign disorders.
NGF Binding (affinity) of TrkA in Nerve associated with pain and cancer
4) Confidence 0.36 Published 1999 Journal J. Clin. Oncol. Section Abstract Doc Link 10561305 Disease Relevance 0.54 Pain Relevance 0.36
Interactions of nerve growth factor (NGF) and its receptor tropomyosin-related kinase (trkA) appear to be critical for maintaining HSV latency.
NGF Binding (Interactions) of trkA in nerve associated with cold sores and nerve growth factor
5) Confidence 0.30 Published 2008 Journal J. Neurovirol. Section Abstract Doc Link 19016376 Disease Relevance 0.40 Pain Relevance 0.23
The purpose of this study was to prove the presence of NGF (nerve growth factor) and its receptor TrkA (tyrosine kinase receptor) with immunofluorescence.
nerve growth factor Binding (presence) of TrkA in nerve associated with nerve growth factor
6) Confidence 0.27 Published 2009 Journal Eur Spine J Section Abstract Doc Link 19399531 Disease Relevance 0.09 Pain Relevance 0.18
The analysis of these specimens revealed the presence of the neurotrophin (NGF) and its own receptor (TrkA) in all cases: the immunohistochemical reaction between the specimens and the specific antibodies marked with FITC was seen under fluoromicroscopy, but in none of the control cases treated with FITC only.
NGF Binding (presence) of TrkA
7) Confidence 0.27 Published 2009 Journal Eur Spine J Section Abstract Doc Link 19399531 Disease Relevance 0.34 Pain Relevance 0.26
The purpose of this study was to prove the presence of NGF (nerve growth factor) and its receptor TrkA (tyrosine kinase receptor) with immunofluorescence.
nerve growth factor Binding (presence) of TrkA in nerve associated with nerve growth factor
8) Confidence 0.27 Published 2009 Journal Eur Spine J Section Abstract Doc Link 19399531 Disease Relevance 0.09 Pain Relevance 0.18
The purpose of this study was to prove the presence of NGF (nerve growth factor) and its receptor TrkA (tyrosine kinase receptor) with immunofluorescence.
NGF Binding (presence) of TrkA in nerve associated with nerve growth factor
9) Confidence 0.27 Published 2009 Journal Eur Spine J Section Abstract Doc Link 19399531 Disease Relevance 0.09 Pain Relevance 0.18
This study demonstrated the presence of NGF and TrkA in specimens collected from degenerative facet joints, suggesting that specific molecules could be used in order to modulate chronic pain in patients with degenerative lumbar spine.
NGF Binding (presence) of TrkA in joints associated with facet joint and lasting pain
10) Confidence 0.27 Published 2009 Journal Eur Spine J Section Abstract Doc Link 19399531 Disease Relevance 0.67 Pain Relevance 0.52
The purpose of this study was to prove the presence of NGF (nerve growth factor) and its receptor TrkA (tyrosine kinase receptor) with immunofluorescence.
NGF Binding (presence) of TrkA in nerve associated with nerve growth factor
11) Confidence 0.27 Published 2009 Journal Eur Spine J Section Abstract Doc Link 19399531 Disease Relevance 0.09 Pain Relevance 0.18
There is considerable evidence showing that the system constituted by the NGF and its high-affinity receptor TrkA plays a fundamental role in the molecular processes underlying the main forms of "persistent" pain.
NGF Binding (affinity) of TrkA associated with pain
12) Confidence 0.27 Published 2009 Journal Eur Spine J Section Abstract Doc Link 19399531 Disease Relevance 0.61 Pain Relevance 0.48
Only a few small molecule NGF antagonists are available, but ALE0540, which inhibits the binding of NGF to TrkA and p75, and PD90780, which inhibits NGF binding to p75, have been proposed to have efficacy in chronic pain models [154,155].
NGF Binding (binding) of TrkA associated with nerve growth factor, lasting pain and antagonist
13) Confidence 0.06 Published 2007 Journal Arthritis Res Ther Section Body Doc Link PMC2206352 Disease Relevance 1.10 Pain Relevance 1.39

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox